Location: Home > Pharma China Web Edition
  • search
  • go
  • News in Focus
  • 1/27/2026China's Early-Stage Drug Advantage Seen Persisting: Pitchbook
  • 1/23/2026China's Commercial Health Insurance Payouts for Innovative Drugs and D...
  • 1/21/2026China Emerges as Credible Challenger to US in AI Drug Discovery, but M...
  • 1/17/2026China Biopharma Innovation Takes Center Stage at 2026 FIC Summit in Sa...
  • 1/13/2026China Biopharma Sees Record Financing and Licensing Activity in 2025
  • 1/13/2026China's 2025 Foreign Investment Catalogue Unlocks Full-Chain Support f...
  • 1/12/2026China's Biopharma Sector Sets New Record for International Licensing D...
  • 1/12/2026China's Innovative Drug Licensing Deals Reach Record Peak in 2025
  • 1/8/2026Asia Emerges as the New Epicenter of Global Biopharma Innovation: McKi...
  • 1/8/2026Chinese Drug Makers Hit Record US$136B in Global Out-Licensing Deals i...
  • 1/6/2026China Biopharma Approvals Surge in December as NMPA Clears Wave of Nov...
  • 12/27/2025China Leads Globally in mRNA-Based Therapeutic Vaccine Development for...
  • 12/27/2025China Biotech Raises $362 Million in 18 Financing Deals in November 20...
  • 12/22/2025China Biopharma Licensing Slows in Value as Overseas Outbound Deals Re...
  • 12/19/2025U.S. Biosecurity Provisions Could Reshape China's Role in Global Biote...
  • 12/17/2025China's New Drug Commercial Insurance Scheme Offers Hope for Patients ...
  • 12/11/2025Chinese Biopharma Sector Posts 22 Financings in November as In Vivo C...
  • 12/11/2025China Tightens Oversight as Domestic Innovators Dominate November Drug...
  • 12/9/2025Global Pharmas Turn to China Not Just for Assets, but for a New R&D Pl...
  • 12/2/2025China Launches National Drug Price Registration System to Propel Marke...
  • 12/2/2025NHC Releases 2024 China Health Statistics Bulletin
  • 12/1/2025MNC's County-Level Ambitions Falter as Strategies Shift From Heavy Inv...
  • 11/28/2025LEK: China's Clinical Trial Sector Enters a New Phase of Innovation an...
  • 11/27/2025MC's China Biopharma Tracker: Dealmaking, Approvals, and $451 Million ...
  • 11/21/2025China's Biopharma Innovation Surges — McKinsey Lays Out Both Opportun...
  • 11/21/2025US Report Flags Risks From China's Expanding Control of Pharma Supply ...
  • 11/20/2025China's Innovation-drug BD Boom Slows as Investors Shift Focus to Prod...
  • 11/18/2025China's October Approvals Signal the Next Five Years of Translational ...
  • 11/18/2025China Biopharma Strikes Record USD 19.9 B in Licensing Deals in Octobe...
  • 11/14/2025MNCs Face Diverging Fortunes and Strategic Reset in China
  • Page:1/2 Total number of articles:54: [First][<<] [1] [2] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group